App aims to boost medication adherence in blood cancer patients
NCT ID NCT06713811
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This trial tests whether a telemonitoring app called Cureety helps blood cancer patients take their oral therapies correctly and manage side effects. Participants will either use the app to report symptoms and track adherence or receive standard follow-up care. The goal is to see if the app improves medication compliance and reduces complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cureety telemonitoring platform
- What this could lead to
- If effective, this app could help blood cancer patients take their oral medications correctly and catch side effects early, improving treatment outcomes and quality of life.
- What could go wrong
- This is a single-center study with 110 participants, so results may not apply broadly. The app's benefit over standard care is unproven, and technical issues or patient reluctance could limit its use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPATHIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinique de l'Europe
RECRUITINGAmiens, 80090, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Clinique de la Baie
RECRUITINGMorlaix, 29672, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Privé du Confluent
RECRUITINGNantes, 44000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact